Challenges in Predicting the Need for Coronary Artery Bypass Grafting at Presentation in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes
Rajendra H. Mehta(Manav Rachna International Institute of Research and Studies), Eric D. Peterson, E. Magnus Ohman(Tarzana Treatment Centers), Charles V. Pollack, Matthew T. Roe(Clinical Research Institute), Robert A. Harrington(Clinical Research Institute), Anita Y. Chen(University of Rochester Medicine), Robert J. Zalenski(Wayne State University), W. Brian Gibler(University of Cincinnati), Elizabeth Clements(Spectrum Health)
Cited by 46
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
|Journal of the American College of Cardiology|2014|3.6k
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
|The Lancet|2018|1.8k
Bivalirudin for Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2006|1.5k